Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate for mental fatigue, pain, and work rehabilitation after traumatic brain injury
2015-002096-14Phase 2Completed
- Sponsor
- Sahlgrenska University Hospital
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of methylphenidate in traumatic brain injury (TBI), sponsored by Sahlgrenska University Hospital. Primary endpoint: Mental Fatigue Scale and work capacity. Started Jul 2015; status: completed.
02
Drugs
methylphenidate
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on 2015-002096-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002096-14.